{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:48:23Z","timestamp":1793947703856,"version":"4.8.0"},"reference-count":21,"publisher":"BMJ","issue":"5","funder":[{"DOI":"10.13039\/100011779","name":"Brien Holden Vision Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Within a surveillance of the prevalence and causes of vision impairment in high-income regions and Central\/Eastern Europe, we update figures through 2015 and forecast expected values in 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Based on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment and presbyopia was estimated for 1990, 2010, 2015, and 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Age-standardised prevalence of blindness and MSVI for all ages decreased from 1990 to 2015 from 0.26% (0.10\u20130.46) to 0.15% (0.06\u20130.26) and from 1.74% (0.76\u20132.94) to 1.27% (0.55\u20132.17), respectively. In 2015, the number of individuals affected by blindness, MSVI and mild vision impairment ranged from 70 000, 630\u2009000 and 610 000, respectively, in Australasia to 980 000, 7.46\u2009million and 7.25\u2009million, respectively, in North America and 1.16\u2009million, 9.61\u2009million and 9.47\u2009million, respectively, in Western Europe. In 2015, cataract was the most common cause for blindness, followed by age-related macular degeneration (AMD), glaucoma, uncorrected refractive error, diabetic retinopathy and cornea-related disorders, with declining burden from cataract and AMD over time. Uncorrected refractive error was the leading cause of MSVI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>While continuing to advance control of cataract and AMD as the leading causes of blindness remains a high priority, overcoming barriers to uptake of refractive error services would address approximately half of the MSVI burden. New data on burden of presbyopia identify this entity as an important public health problem in this population. Additional research on better treatments, better implementation with existing tools and ongoing surveillance of the problem is needed.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311258","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T16:16:44Z","timestamp":1521130604000},"page":"575-585","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":325,"title":["Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections"],"prefix":"10.1136","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8169-1645","authenticated-orcid":false,"given":"Rupert R A","family":"Bourne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-5227","authenticated-orcid":false,"given":"Jost B","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7265-931X","authenticated-orcid":false,"given":"Alain M","family":"Bron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vittoria","family":"Cicinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth R","family":"Flaxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill E","family":"Keeffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-5162","authenticated-orcid":false,"given":"Janet","family":"Leasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kovin","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Pesudovs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinan","family":"Saadine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J","family":"Silvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tahhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh R","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Y","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5866-4446","authenticated-orcid":false,"given":"Serge","family":"Resnikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"2020050713011102000_102.5.575.1","first-page":"1603","article-title":"Global, regional, and national disability\u2010adjusted life years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20102015: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2015 Study","volume":"38","author":"\u00a0GBD 2015 DALYs and HALE Collaborators","year":"2016","journal-title":"Lancet"},{"key":"2020050713011102000_102.5.575.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.05.025"},{"key":"2020050713011102000_102.5.575.3","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304033"},{"key":"2020050713011102000_102.5.575.4","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70113-X"},{"key":"2020050713011102000_102.5.575.5","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","article-title":"Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis","volume":"5","author":"Bourne","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2020050713011102000_102.5.575.6","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2020050713011102000_102.5.575.7","unstructured":"Global Vision Database. http:\/\/www.globalvisiondata.org (accessed 1 Aug 2017)."},{"key":"2020050713011102000_102.5.575.8","doi-asserted-by":"publisher","DOI":"10.3109\/09286586.2012.741279"},{"key":"2020050713011102000_102.5.575.9","doi-asserted-by":"crossref","unstructured":"Gelman A , Carlin JB , Stern HS , et al . Bayesian Data Analysis. 3rd edn. London: Chapman & Hall\/CRC Press, 2013.","DOI":"10.1201\/b16018"},{"key":"2020050713011102000_102.5.575.10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajo.2012.01.026","article-title":"Prevalence and correction of near vision impairment at seven sites in China, India, Nepal, Niger, South Africa, and the United States","volume":"154","author":"He","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"2020050713011102000_102.5.575.11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ophtha.2013.06.051","article-title":"Age-related prevalence and met need for correctable and uncorrectable near vision impairment in a multi-country study","volume":"121","author":"He","year":"2014","journal-title":"Ophthalmology"},{"key":"2020050713011102000_102.5.575.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)70128-X"},{"key":"2020050713011102000_102.5.575.13","doi-asserted-by":"publisher","DOI":"10.3109\/09286586.2013.789915"},{"key":"2020050713011102000_102.5.575.14","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2015 Revision, 2015. (accessed 19 May 2017)."},{"key":"2020050713011102000_102.5.575.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.003"},{"key":"2020050713011102000_102.5.575.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481"},{"key":"2020050713011102000_102.5.575.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062655"},{"key":"2020050713011102000_102.5.575.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102673"},{"key":"2020050713011102000_102.5.575.19","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2377"},{"key":"2020050713011102000_102.5.575.20","first-page":"3309","article-title":"Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study","volume":"41","author":"Wolfs","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2020050713011102000_102.5.575.21","doi-asserted-by":"publisher","DOI":"10.3310\/hta11030"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:56:22Z","timestamp":1601110582000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,19]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311258"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311258","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]}}}